HKSE - Delayed Quote HKD
WuXi Biologics (Cayman) Inc. (2269.HK)
22.550
+0.850
+(3.92%)
At close: 4:08:14 PM GMT+8
Major Holders
Breakdown | |
---|---|
14.84% | % of Shares Held by All Insider |
35.14% | % of Shares Held by Institutions |
41.26% | % of Float Held by Institutions |
322 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Boston Common Asset Management, LLC | 869k | Mar 31, 2024 | 0.02% | 19,595,949 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
VANGUARD WORLD FUND-Vanguard International Growth Fund | 66.04M | Feb 28, 2025 | 1.60% | 1,489,269,599 |
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 48.98M | Jan 31, 2025 | 1.19% | 1,104,394,646 |
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd | 44.51M | Jan 31, 2025 | 1.08% | 1,003,690,679 |
iShares, Inc.-iShares Core MSCI Emerging Markets ETF | 31.3M | Mar 31, 2025 | 0.76% | 705,769,876 |
AIM Investment Fd.s -Invesco Developing Markets Fd. | 29.78M | Jan 31, 2025 | 0.72% | 671,572,802 |
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. PORT. | 9.82M | Jan 31, 2025 | 0.24% | 221,531,192 |
J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci | 9.32M | Jan 31, 2025 | 0.23% | 210,244,917 |
iShares Trust-iShares MSCI China ETF | 8.96M | Mar 31, 2025 | 0.22% | 202,025,443 |
Dimensional Emerging Markets Value Fund | 8.24M | Jan 31, 2025 | 0.20% | 185,924,743 |
iShares, Inc.-iShares MSCI Emerging Markets ETF | 7.38M | Mar 31, 2025 | 0.18% | 166,396,444 |
Related Tickers
1177.HK SINO BIOPHARM
3.880
+1.31%
1801.HK INNOVENT BIO
51.700
-1.15%
6160.HK BeiGene, Ltd.
140.700
-0.21%
1530.HK 3SBIO
11.560
0.00%
1548.HK GENSCRIPT BIO
11.120
+3.35%
9926.HK Akeso, Inc.
84.250
+0.66%
6622.HK Zhaoke Ophthalmology Limited
1.640
-1.20%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.490
+2.05%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
328.800
+4.38%
1873.HK VIVA BIOTECH
1.440
+0.70%